Design, Synthesis, In vitro and In silico Alpha Glucosidase and Lipoxygenase Inhibition Studies of Copper(II) Oxamide Complexes

Abstract

AbstractMetal complexes have pivotal applications in catalysis, photochemistry, and biological systems. Due to their unique chemical properties, metal complexes occupy a coveted place in the field of drug design. The present study includes the synthesis of symmetrical oxamides (O1–O11) and their copper complexes (C1–C11) that have potential to inhibit α‐glucosidase and lipoxygenase enzymes. To elucidate the structures of these compounds, spectroscopic investigations including mass spectrometry, 1H‐NMR spectroscopy, UV‐Visible spectroscopy and IR spectroscopy were adapted along with CHN elemental analysis. The spectroscopic investigations suggested that the synthesized complexes to be square planar with metal to ligand ratio 1 : 2. All compounds were scanned for potential inhibitory studies against α‐glucosidase and lipoxygenase enzyme. Their structure activity relationships (SAR) were also established. It was found that all synthesized compounds are strong inhibitors of α‐glucosidase when compared to standard 1‐deoxynojirimycin. It was noteworthy that presence of substituent played a significant role for the enhancing potential inhibitory skills of the compounds. The results obtained were also compared with molecular docking studies. A similar inhibition trend was observed between experimental inhibitory activity and docking energies. The current work presents a special class of Cu(II) coordination complexes from the perspective of their biological as well as structural features.